Search For "pharma"
Glenmark cuts COVID-19 drug Favipiravir price by 27 pc
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
Read More
Fitch affirms Glenmark Pharmaceuticals at BB, withdraws proposed bond rati
Updated : 5 years, 8 months ago IST
Singapore, July 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals' long-term issuer default rating at BB with a stable outlook.
Read More
DCGI instructs pharma giants manufacturing remdesivir to upload details of
Updated : 5 years, 8 months ago IST
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug
Read More
India's pharma industry an asset for the world: PM Narendra Modi
Updated : 5 years, 8 months ago IST
New Delhi [India], July 9 (ANI): In a virtual global address, Prime Minister Narendra Modi on Thursday said Indian pharmaceutical industry has been an "asset" not just for its own country but also for the entire world as it leads to "reducing the cost of medicine" for developing countries
Read More
Indian pharma compliance standards improving, regulatory risks here to sta
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
Zydus gets Mexican regulator nod for Desidustat in test management of COVI
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 6 (ANI): Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its one of its lead research candidate Desidustat to be tested in the management of COVID-1
Read More
DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila
Updated : 5 years, 8 months ago IST
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
Read More
NPPA monitoring price of critical medical equipment for COVID-19
Updated : 5 years, 8 months ago IST
New Delhi [India], July 2 (ANI): In the wake of COVID-19 pandemic, government is striving to ensure sufficient availability of critical medical equipment for clinical management of COVID-19 in the country, said Ministry of Chemicals and Fertilizers.
Read More
Brazil announces agreement with UK to produce COVID-19 vaccine
Updated : 5 years, 8 months ago IST
Sao Paulo [Brazil], June 28 (Xinhua/ANI): The Brazilian Ministry of Health on Saturday announced an agreement with the United Kingdom to acquire technology to locally produce a vaccine against COVID-19, that is, currently being developed by the University of Oxford and British pharmaceutical
Read More
Carlyle to pick up 20 pc stake in Piramal pharma business for $490 million
Updated : 5 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 27 (ANI): The Carlyle Group has agreed to pick up 20 per cent stake in Ajay Piramal's pharma business for 490 million dollars (about Rs 3,698 crore), making it one of the largest private equity deals in the Indian pharmaceutical sector.
Read More
Supply Chain Labs and QGLUE launch the Healthcare and Pharma Supply Chain
Updated : 5 years, 8 months ago IST
Gurugram (Haryana) [India], June 26 (ANI/BusinessWire India): The current COVID crisis has shed light on the supply chain challenges and vulnerabilities facing industries, including pharma and healthcare companies.
Read More